Cargando…
Review of Preclinical and Clinical Studies of Bone Marrow-Derived Cell Therapies for Intracerebral Hemorrhage
Stroke is the second leading cause of mortality worldwide, causing millions of deaths annually, and is also a major cause of disability-adjusted life years. Hemorrhagic stroke accounts for approximately 10 to 27% of all cases and has a fatality rate of about 50% in the first 30 days, with limited tr...
Autores principales: | Rosado-de-Castro, Paulo Henrique, de Carvalho, Felipe Gonçalves, de Freitas, Gabriel Rodriguez, Mendez-Otero, Rosalia, Pimentel-Coelho, Pedro Moreno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028871/ https://www.ncbi.nlm.nih.gov/pubmed/27698671 http://dx.doi.org/10.1155/2016/4617983 |
Ejemplares similares
-
Hyperacute transplantation of umbilical cord mesenchymal stromal cells in a model of severe intracerebral hemorrhage
por: Mello, Tanira Giara, et al.
Publicado: (2022) -
Editorial: New Insights into the Pathophysiology and Treatment of Neonatal Hypoxic–Ischemic Encephalopathy
por: Rosado-de-Castro, Paulo Henrique, et al.
Publicado: (2016) -
Radiopharmaceutical Stem Cell Tracking for Neurological Diseases
por: Rosado-de-Castro, Paulo Henrique, et al.
Publicado: (2014) -
Bone Marrow-Derived Cells as a Therapeutic Approach to Optic Nerve Diseases
por: Mesentier-Louro, Louise A., et al.
Publicado: (2016) -
The Current State of Cell Therapies for Cerebrovascular Diseases
por: Jolkkonen, Jukka, et al.
Publicado: (2016)